Exploring the Biologically Relevant Chemical Space for Drug Discovery
Authors:
- Cai-Xia DuCDCai-Xia Du
- Ben HuBHBen Hu
- Zheng-Kun KuangZKZheng-Kun Kuang
- Rong WangRWRong Wang
- Shi-Yu FengSFShi-Yu Feng
- Hong-Yu ZhangHZHong-Yu Zhang
- De-Xin KongDKDe-Xin Kong
- 1 November 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 53 (11) , 2820-2828
Abstract
Both recent studies and our calculation suggest that the physicochemical properties of launched drugs changed continuously over the past decades. Besides shifting of commonly used properties, the average biological relevance (BR) and similarity to natural products (NPs) of launched drugs decreased, reflecting the fact that current drug discovery deviated away from NPs. To change the current situation characterized by high investment but low productivity in drug discovery, efforts should be made to improve the BR of the screening library and hunt drugs more effectively in the biologically relevant chemical space. Additionally, a multiple dimensional molecular descriptor, named the biologically relevant spectrum (BRS) was proposed for quantitative structure–activity relationships (QSAR) study or screening library preparation. Prediction models for 43 biological activity categories were developed with BRS and support vector machine (SVM). In most cases, the overall prediction accuracies were around 95% and the Matthew’s correlation coefficients (MCC) were over 0.8. Thirty-seven out of 48 drug-activity associations were successfully predicted for drugs that launched from 2006 to 2012, which were not included in the training data set. A web-server named BioRel (http://ibi.hzau.edu.cn/biorel) was developed to provide services including BR, BRS calculation, activity class, and pharmacokinetic property prediction.Keywords
This publication has 63 references indexed in Scilit:
- Estimation of the size of drug-like chemical space based on GDB-17 dataJournal of Computer-Aided Molecular Design, 2013
- Stochastic Voyages into Uncharted Chemical Space Produce a Representative Library of All Possible Drug-Like CompoundsJournal of the American Chemical Society, 2013
- Do Biologically Relevant Compounds Have More Chance To Be Drugs?Journal of Chemical Information and Modeling, 2009
- 970 Million Druglike Small Molecules for Virtual Screening in the Chemical Universe Database GDB-13Journal of the American Chemical Society, 2009
- Distribution patterns of small-molecule ligands in the protein universe and implications for origin of life and drug discoveryGenome Biology, 2007
- Why has R&D productivity declined in the pharmaceutical industry?Expert Opinion on Drug Discovery, 2006
- ZINC − A Free Database of Commercially Available Compounds for Virtual ScreeningJournal of Chemical Information and Modeling, 2004
- Preferential Attachment in the Protein Network EvolutionPhysical Review Letters, 2003
- Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric GroupsJournal of Chemical Information and Computer Sciences, 2002
- The art and practice of structure-based drug design: A molecular modeling perspectiveMedicinal Research Reviews, 1996